登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JAMA，3月25日，Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China》

  • 来源专题：COVID-19科研动态监测
  • 编译者： xuwenwhlib
  • 发布时间：2020-03-26

  • Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

    Shaobo Shi, MD1,2,3; Mu Qin, MD4; Bo Shen, MD1,2,3; et alYuli Cai, MD5; Tao Liu, MD1,2,3; Fan Yang, MD6; Wei Gong, MMSC7; Xu Liu, MD, PhD4; Jinjun Liang, MD, PhD1,2,3; Qinyan Zhao, MD, PhD1,2,3; He Huang, MD, PhD1,2,3; Bo Yang, MD, PhD1,2,3; Congxin Huang, MD, PhD1,2,3

    Author Affiliations Article Information

    JAMA Cardiol. Published online March 25, 2020. doi:10.1001/jamacardio.2020.0950

    Abstract

    Importance Coronavirus disease 2019 (COVID-19) has resulted in considerable morbidity and mortality worldwide since December 2019. However, information on cardiac injury in patients affected by COVID-19 is limited.

    Objective To explore the association between cardiac injury and mortality in patients with COVID-19.

    Design, Setting, and Participants This cohort study was conducted from January 20, 2020, to February 10, 2020, in a single center at Renmin Hospital of Wuhan University, Wuhan, China; the final date of follow-up was February 15, 2020. All consecutive inpatients with laboratory-confirmed COVID-19 were included in this study.

  • 原文来源：https://jamanetwork.com/journals/jamacardiology/fullarticle/2763524?resultClick=1
134浏览量
原文链接
相关报告

  • 《MedRxiv，3月24日，Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-25
    • Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: A single center retrospective cohort study Fan Zhang, Deyan Yang, Jing Li, Peng Gao, Taibo Chen, Zhongwei Cheng, Kangan Cheng, Quan Fang, Wan Pan, Chunfeng Yi, Hongru Fan, Yonghong Wu, Liwei Li, Yong Fang, Juan Liu, Guowei Tian, Liqun He doi: https://doi.org/10.1101/2020.03.21.20040121 Abstract [Background] Since December 2019, a cluster of coronavirus disease 2019 (COVID-19) occurred in Wuhan, Hubei Province, China and spread rapidly from China to other countries. In-hospital mortality are high in severe cases and cardiac injury characterized by elevated cardiac troponin are common among them. The mechanism of cardiac injury and the relationship between cardiac injury and in-hospital mortality remained unclear. Studies focused on cardiac injury in COVID-19 patients are scarce. [Objectives] To investigate the association between cardiac injury and in-hospital mortality of patients with confirmed or suspected COVID-19. [Methods] Demographic, clinical, treatment, and laboratory data of consecutive confirmed or suspected COVID-19 patients admitted in Wuhan No.1 Hospital from 25th December, 2019 to 15th February, 2020 were extracted from electronic medical records and were retrospectively reviewed and analyzed. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    87浏览量
    原文链接

  • 《JAMA，3月25日，An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-03-26
    • An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases Chengzhi Yang, MD, PhD1; Zening Jin, MD, PhD1 JAMA Cardiol. Published online March 25, 2020. doi:10.1001/jamacardio.2020.0934 The outbreak of novel coronavirus disease 2019 (COVID-19), which emerged in Wuhan, China, in December 2019, has rapidly spread to more than 58 countries and areas.1 As of March 1, 2020, about 79?968 cases in mainland China have been confirmed and 2873 deaths have occurred.1 The Chinese government is mustering medical personnel around the country to treat patients in Hubei province and preventing further spread of COVID-19 in every region of the country. At the same time, several studies concerning the epidemiological and clinical features of COVID-19 have been published in a timely manner, which has greatly helped health care workers and policy makers to understand COVID-19. Reading these reports, we noticed that many patients with COVID-19 had comorbid chronic cardiovascular diseases (CVDs), which collectively represent the most common noncommunicable epidemic in China currently. Among 44?672 individuals confirmed to have COVID-19 as of February 11, 2020, 2683 patients (12.8%) had hypertension and 873 (4.2%) had CVDs,2 which were the most common coexisting conditions in patients hospitalized with COVID-19.3,4 Furthermore, patients with comorbid CVDs were more likely to have severe illness associated with COVID-19 and had a much higher fatality rate: 10.5% for those with CVDs and 6.0% for hypertension, while the fatality rate was 0.9% in patients who reported no comorbid conditions.2 This information indicated that individuals with underlying chronic CVDs were both more susceptible to COVID-19 and more prone to critical conditions and death. It is well known that acute pulmonary infection can potentially destabilize cardiac diseases, such as heart failure and coronary artery disease. Then deterioration of cardiac diseases would exacerbate COVID-19 management in turn.
    116浏览量
    原文链接